Scott T. Garrett

Scott T. Garrett, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Hologic Inc and HCW Biologics Inc. We count 13 filings; the first trade dates from 1 January 2016 and the latest from 29 July 2026.

In open-market terms, that means 5 purchases worth €1.3M on one side and 2 sales worth €1.4M on the other. Sales outweigh purchases by €70k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 4 share grants and 2 option exercises. Since January 2026: 2 purchases and no sales on the market.

Half of the purchases are above €125k and half below. Of 5 purchases, 5 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster.

On 31 July 2026 came the latest disclosure, an open-market purchase for €18k in HCW Biologics Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.